Soleno Therapeutics, Inc.
SLNO
$43.64
-$0.12-0.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.01M | -4.71M | -43.77M | -55.98M | -76.62M |
| Total Depreciation and Amortization | 502.00K | 502.00K | 504.00K | 503.00K | 500.00K |
| Total Amortization of Deferred Charges | 9.00K | 9.00K | 8.00K | -- | -- |
| Total Other Non-Cash Items | 10.38M | 10.01M | 16.87M | 28.88M | 55.68M |
| Change in Net Operating Assets | 6.56M | -18.42M | -6.36M | 2.61M | 5.51M |
| Cash from Operations | 43.45M | -12.61M | -32.75M | -23.99M | -14.93M |
| Capital Expenditure | -1.00K | -9.00K | -5.00K | -8.00K | -191.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -91.44M | -7.91M | 22.94M | 6.45M | 4.23M |
| Cash from Investing | -91.44M | -7.92M | 22.94M | 6.44M | 4.04M |
| Total Debt Issued | -- | -- | -- | 49.89M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 217.98M | 15.90M | 3.28M | 7.18M | 2.28M |
| Repurchase of Common Stock | 0.00 | -33.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 178.00K | -178.00K | -62.00K | -- | -- |
| Cash from Financing | 218.15M | 15.69M | 3.22M | 57.06M | 2.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.17M | -4.83M | -6.60M | 39.52M | -8.61M |